Graft versus host disease (GvHD) is a generalised immune system reaction following allogeneic hematopoietic stem cell transplantation (AHSCT) in patients with acquir...

The need to improve efficiency and effectiveness of clinical trials has been well documented – and a new survey reveals that the life sciences industry is focusing o...

Today, more than ever, pharmaceutical and biotech companies are under great pressure to run their business in a way that makes drug development processes more effici...

The use of biomarkers in drug discovery and development has exploded at an unprecedented rate since the turn of the century. With recent scientific and technological...

As financial pressures continue to bear down on the clinical research sector, it is vital that both sponsor companies and the CROs that conduct their studies continu...